GlassScriptPhysician profile
Richard Cheng
NPI 1437426699
$11,819.63
in general payments reported to CMS, 2019-2025
14 companies · $4,625 in 2025
The $4,625 reported for 2025 was more than what 91% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $504 · 2020: $75.69 · 2021: $25.77 · 2022: $1,603 · 2023: $1,265 · 2024: $3,722 · 2025: $4,625.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,718 · Consulting Fee: $3,975 · Travel and Lodging: $919.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,717.52 |
| Consulting Fee | $3,975.00 |
| Travel and Lodging | $918.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $5,182.14 | 2019-2025 | Sapien 3 Ultra Resilia, Pascal |
| Abbott Laboratories | $2,622.71 | 2019-2025 | Mitraclip, Triclip, Cardiomems |
| Ancora Heart, INC. | $1,426.59 | 2022-2025 | Accucinch |
| Siemens Medical Solutions USA, INC. | $1,381.28 | 2021-2022 | |
| Procyrion, INC. | $284.04 | 2024 | |
| Heartflow, INC. | $282.54 | 2025 | |
| Cardiac Dimensions, INC. | $248.89 | 2024 | |
| Medtronic, INC. | $214.26 | 2025 | Symplicity G3, Ffrangio |
| Penumbra, INC. | $60.00 | 2024 | Indigo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.73 | 2022 | |
| Ars Pharmaceuticals Operations, INC. | $28.11 | 2025 | Neffy |
| Teleflex LLC | $23.68 | 2025 | Trapliner |
| Cardiva Medical, INC. | $18.11 | 2023 | Cardiva Vascade 6/7f Vcs |
| Novo Nordisk INC | $17.55 | 2024 | Ozempic, Rybelsus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Cheng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.